Farther Finance Advisors, LLC Regencell Bioscience Holdings LTD Call Options Transaction History
Farther Finance Advisors, LLC
- $5 Trillion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RGC
# of Institutions
8Shares Held
19.8KCall Options Held
0Put Options Held
0-
Greenfield Savings Bank11KShares$166,9800.09% of portfolio
-
Geode Capital Management, LLC Boston, MA6.82KShares$103,4660.0% of portfolio
-
Royal Bank Of Canada Toronto, A6948Shares$14,3900.0% of portfolio
-
Tower Research Capital LLC (Trc) New York, NY698Shares$10,5950.0% of portfolio
-
Black Rock Inc. New York, NY238Shares$3,6120.0% of portfolio
About Regencell Bioscience Holdings Ltd
- Ticker RGC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,012,900
- Market Cap $198M
- Description
- Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated...